Sterling
Pfizer logo
Pfizer
CSL logo
CSL

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Pfizer 15.034, CSL 3.6525.

* CSL reports semi-annually. Values are evenly split across both quarters within each half.

Pfizer vs CSL Net Worth and Market Cap

Pfizer (PFE) and CSL (CSL.AX) are peers in Vaccines. Pfizer reported revenue of $15.0B as of Q2 2026, compared with $7.3B for CSL. Pfizer leads on revenue.

Pfizer's gross margin is 72.8% versus 44.4% for CSL. Pfizer's net margin is -1.6% versus -40.2% for CSL.

Key differences

  • Revenue growth from Q2 2025 to Q2 2026: Pfizer +2.6%, CSL +0.7%.
  • Pfizer keeps more of its revenue as operating profit: a 31.3% operating margin, against 19.0% at CSL.
  • Pfizer's KPIs on Sterling include Abrysvo Revenues by Region (Quarterly) and Comirnaty Revenues by Region (Quarterly).
  • CSL's KPIs on Sterling include Behring Revenue by Therapy (Annual) and Behring IVIG vs SCIG Revenue (Annual).

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, CSL.
MetricPfizerCSL
Market Cap--
Revenue$15.03B$7.30B
Cost of Revenue$4.09B$4.06B
Gross Profit$10.94B$3.24B
Operating Income$4.71B$1.39B
Net Income$-246.00M$-2.94B
R&D Expense$2.81B$614.00M
Earnings Per Share-$0.04-$6.14
Gross Margin72.8%44.4%
Operating Margin31.3%19.0%
Net Profit Margin-1.6%-40.2%
Free Cash Flow$302.00M$1.76B
Cumulative Free Cash Flow$356.70B$21.56B
Operating Cash Flow$835.00M$2.09B
Cash & Equivalents$976.00M$1.51B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites